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eat-11 encodes GPB-2, a Gb5 ortholog that interacts with Goa
and Gqa to regulate C. elegans behavior
Merrilee Robatzek*‡, Tim Niacaris†‡, Kate Steger†, Leon Avery†
and James H. Thomas*
In C. elegans, a Go/Gq signaling network regulates Results and discussion
Genetic analysis indicates that the gene eat-11 is involvedlocomotion and egg laying [1–8]. Genetic analysis
shows that activated Ca21/calmodulin-dependent in the GOA-1 Goa/EGL-30 Gqa signaling network (Figure
1a; [3, 9]). To determine the molecular identity of eat-protein kinase II (CaMKII) is suppressed by
perturbations of this network, which include loss of 11, we refined the physical map position of eat-11 by using
three-factor mapping, and we used transgenic rescue tothe GOA-1 Goa, DGK-1 diacylglycerol kinase, EAT-
16 G protein g subunit–like (GGL)-containing RGS determine that eat-11 encodes GPB-2, an ortholog of the
human Gb5 protein. Gb proteins form highly ordered,protein, or an unidentified protein encoded by the
gene eat-11 [9]. We cloned eat-11 and report that it seven-bladed propeller structures that are composed of
seven WD40 motifs [12, 13]. We identified mutations inencodes the Gb5 ortholog GPB-2. Gb5 binds
specifically to GGL-containing RGS proteins, and the the gpb-2 coding sequence in eight eat-11 alleles (hence-
forth referred to as gpb-2 alleles). All affected residues lieGb5/RGS complex can promote the GTP-
hydrolyzing activity of Ga subunits [10, 11]. However, within the conserved core of the GPB-2 WD40 motifs
(Figure 1b). Six missense mutations alter residues thatlittle is known about how this interaction affects
G protein signaling in vivo. In addition to EAT-16, are conserved among GPB-2, Gb5, and the highly related
Gb1 protein, and this finding indicates that these muta-the GGL-containing RGS protein EGL-10
participates in Go/Gq signaling; EGL-10 appears to tions are likely to cause significant disruption of GPB-2
function. The sa603 and ad541 mutations result in prema-act as an RGS for the GOA-1 Goa, while EAT-16
appears to act as an RGS for the EGL-30 Gqa [4, 5]. ture truncation of the GPB-2 protein. sa603 creates a stop
codon after the second WD40 motif, and this featureWe have combined behavioral,
electrophysiological, and pharmacological makes it an excellent candidate for a null allele. All of
the alleles are recessive, consistent with loss-of-functionapproaches to show that GPB-2 is a central
member of the Go/Gq network and that GPB-2 may (lf) mutations.
interact with both the EGL-10 and EAT-16 RGS
proteins to mediate the opposing activities of Goa gpb-2(lf) mutants exhibit deep body bends during locomo-
and Gqa. These interactions provide a mechanism tion (Figure 2a, upper right panel), a phenotype also seen
for the modulation of behavior by antagonistic G in goa-1(lf) mutants [1] and in animals that overexpress
protein networks. EGL-30 [3]. Transgenic overexpression of GPB-2 results
in a flattened sinusoidal waveform (Figure 2a, lower pan-
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Seven of the eight gpb-2 mutations, along with goa-1, dgk-
1, and eat-16 alleles, were isolated as suppressors of the
Published: 20 February 2001 lethargic locomotion caused by activated UNC-43 CaM-
KII [9]. In addition, these mutations suppress the egg-
Current Biology 2001, 11:288–293 laying defect caused by activated UNC-43, and this indi-
cates that gpb-2 regulates locomotory-activity level and
0960-9822/01/$ – see front matter egg laying similarly, in concert with the GOA-1/EGL-30
Ó 2001 Elsevier Science Ltd. All rights reserved. network [9]. Since both gpb-2 and eat-16 loss-of-function
mutations were recovered in the same screen, GPB-2 may
interact with the GGL-containing RGS EAT-16, by anal-
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Figure 1
(a) A model of the GOA-1(Goa)/EGL-30(Gqa)
signaling network. This model is based on
the work of several groups [1–8]. The Ga
subunits GOA-1 and EGL-30 (circles)
couple to serpentine receptors in the plasma
membrane and are regulated by the GGL-
containing RGS proteins EGL-10 and EAT-
16 (triangles), respectively. The Gqa-
associated receptor, the EGL-30 Gqa, and
EGL-30 effectors (green) act to increase the
locomotion rate and egg laying, while the Goa-
associated receptor, the GOA-1 Goa, and
GOA-1 effectors (red) act to decrease both
behaviors. EGL-30 activates the EGL-8
phospholipase Cb (PLCb), which cleaves
phosphatidylinositol 4, 5-bisphosphate
(PIP2) into diacylglycerol (DAG) and inositol-1,
4, 5-triphosphate [23]. GOA-1 may
activate DGK-1 (a diacylglycerol kinase),
which opposes EGL-30/PLCb signaling by
depleting DAG. (b) Alignment of GPB-2 with
the human Gb5 and bovine Gb1 proteins.
Identical residues are boxed in black, and
residues with conservative changes are
boxed in gray. The conserved cores of the
WD40 repeat motifs in Gb1 [12] are
underlined and numbered. Arrowheads
indicate the sequence alterations in each eat-
11/gpb-2 allele. DNA sequencing was
performed on both strands of bulk PCR
product generated directly from mutant
genomic DNA. We made alignments by using
Clustal W 1.4 with default parameters
ogy to mammalian systems. If GPB-2 interacts solely with interact only with EAT-16. Since the variable gpb-2 loco-
motion phenotype complicates quantitative analysis, weEAT-16, gpb-2(lf) mutants might exhibit phenotypes simi-
lar to those of eat-16(lf) mutants. We observed that most also compared the eat-16 and gpb-2 egg-laying phenotypes.
Egg-laying activity is only moderately affected in mostgpb-2 alleles, including the sa603 putative null, confer
intermittent locomotion that includes periods of inactivity gpb-2 mutants, including the sa603 putative null, in con-
trast to goa-1, dgk-1, and eat-16 loss-of-function mutants,punctuated by brief periods of hyperactive movement. In
contrast, eat-16(lf) mutants are more uniformly hyperac- which lay eggs of much earlier stages (Figure 2b; [1, 2,
5, 9]). Consequently, both the locomotion and egg-layingtive, and this observation suggests that GPB-2 may not
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Figure 2 phenotypes suggest that if GPB-2 interacts with EAT-
16, it must also interact with another modifier of G protein
signaling. Since EGL-10 is another GGL-containing RGS
protein that controls locomotion and egg laying [4], it is
an excellent candidate for this second GPB-2 partner.
EAT-16 and EGL-10 have opposing effects on locomo-
tion and egg laying; egl-10(lf) mutants have a dramatic
reduction in locomotory and egg-laying activity [4]. Since
loss-of-function mutations in gpb-2 have phenotypes inter-
mediate between those of eat-16(lf) and egl-10(lf), we pro-
pose that GPB-2 regulates the opposing activities of Goa
and Gqa via both the EAT-16 and the EGL-10 RGS
proteins. Similar models have been proposed based on
independent studies of gpb-2 deletion mutants [14 (this
issue of Current Biology), 15]. Two gpb-2 alleles, sa833
and sa604, lay eggs of significantly earlier stages (Figure
2b) and have greater locomotory activity compared to
other gpb-2 alleles. sa833 and sa604 are phenotypically
similar to eat-16(lf), and their similarity suggests that they
may preferentially disrupt EAT-16 function. How might
such a specific disruption occur? The residues mutated
in sa833 and sa604 are predicted to lie in the fifth and
sixth propeller blades, which are thought to bind to GGL-
containing RGS proteins [10, 12, 13]. This prediction sug-
gests that these mutations specifically disrupt an interac-
tion between GPB-2 and the EAT-16 RGS.
In addition to causing defects in locomotion and egg lay-
ing, activated UNC-43 CaMKII causes defects in defeca-
tion behavior; these defects severely reduce the percent-
age of defecation cycles that exhibit an enteric muscle
contraction (EMC) (Figure 2c; [16, 17]). Loss-of-function
mutations in gpb-2 or eat-16 significantly suppress this unc-
43 defect, and this suppression indicates an increase in
ad541 (p , 0.002) and sa603 (p , 0.0001) but not significantly
different from sa765 (p . 0.5). eat-16 alleles are significantly
different from ad541, sa603, and sa765 (p , 0.0001 for each
comparison) but not significantly different from sa604 or sa833 (p .
0.1 for each comparison). (c) Mutations in gpb-2 and in the eat-16
RGS affect enteric muscle contraction (EMC) similarly. We observed
and recorded the frequency of EMC at 198C as described [24] by
using young-adult hermaphrodites. unc-43(gf) is unc-43(n498),(a) Perturbations in gpb-2 affect locomotion. gpb-2(sa765) and other
which encodes an activated CaMKII [17]. Thirty to eighty defecationgpb-2 loss-of-function mutants sometimes move with deep bends
cycles were observed for each genotype. Percent EMC wasand leave large-amplitude sinusoidal tracks. Transgenic
determined by the combination of raw data from animals of the sameoverexpression (xs) of gpb-2 causes variably uncoordinated
genotype. The error bars indicate standard error. The frequency ofmovement resulting in straight, flat tracks in most transgenic animals.
EMCs observed in gpb-2; unc-43(gf) and eat-16; unc-43(gf) doubleWe were able to distinguish gpb-2(xs) transgenic animals from
mutants differs significantly from the unc-43(gf) single mutant bynontransgenic controls by scoring either the uncoordinated phenotype
Fisher’s exact test (p , 0.0002 for all comparisons, including gpb-or the pattern of their tracks (p , 0.05). The bottom right panel was
2(sa603); unc-43(gf), for which data is not shown). By the samephotographed at lower magnification. (b) Egg-laying activity is
test, the putative null goa-1 allele, sa734 [9], fails to suppress unc-moderately affected by most gpb-2 loss-of-function mutations. Two
43(gf) (p . 0.5), as does goa-1(n363) (data not shown), a deletiongpb-2 loss-of-function alleles, sa604 and sa833, cause a severe defect
allele [2]. The putative null dgk-1 allele, sy428 [5], slightly enhancesin egg-laying activity that is similar to the defect caused by eat-16
the unc-43(gf) EMC defect (0.01 , p , 0.05). Another dgk-1(lf)RGS mutations. Assays were performed as in [9], and at least 60
allele, sa748 [9], also fails to suppress unc-43(gf) (data not shown).eggs were scored for each genotype. Data for sy438 and sa833
Red asterisks indicate statistically significant differences fromare also shown in [9], as are some of the data for N2 (wild type).
unc-43(gf).sa609 and sy438 are putative null alleles of eat-16 [5, 9]. Applying
the Mann-Whitney U test to raw data shows that N2 is different from
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Figure 3 enteric muscle activity (Figure 2c). In contrast, loss-of-
function mutations in dgk-1 or goa-1 fail to suppress the
activated UNC-43 EMC defect. This suppression profile
is different from the locomotory and egg-laying systems,
in which loss-of-function mutations in all four genes sup-
press the activated UNC-43 phenotypes. Since loss of the
EGL-30 Gqa decreases enteric muscle activity [16], it is
likely that in this tissue a GPB-2/EAT-16 RGS complex
negatively regulates EGL-30 independently of GOA-1
and DGK-1.
gpb-2 was first linked to G protein signaling through the
analysis of pharyngeal pumping [3]. The nonspecific cho-
linergic agonist arecoline permanently blocks the pump-
ing of gpb-2(ad541) pharynxes and arrests growth, but it
only transiently affects wild-type animals [3, 18]. egl-30(lf)
mutations allow gpb-2(ad541) mutants to grow in the pres-
ence of arecoline [3], and this finding suggests that a
muscarinic acetylcholine receptor lies upstream of EGL-
30 and GPB-2 in pharyngeal muscle. To test this, we
exposed gpb-2 mutants to arecoline in the presence of
atropine, a muscarinic acetylcholine–receptor antagonist.
We found that atropine significantly restores growth to
all gpb-2 mutants exposed to arecoline (Figure 3a). We
conclude that one function of GPB-2 may be to regulate
EGL-30 Gqa activity downstream of a pharyngeal musca-
rinic receptor.
We examined electropharyngeograms (EPGs) to deter-
mine whether GPB-2 also affects pharyngeal electrophysi-
ology. EPGs reflect charge movements in pharyngeal
muscle that cause movement of the pharynx [19]. We
found that gpb-2(lf) mutants have a significant decrease
in negative current spikes caused by firing of the M3
motorneuron (Figure 3b,c; [19, 20]). M3 acts to shorten
the pharyngeal action potential [20, 21]. Consistent with
this, gpb-2(ad541) has longer action potential durations
than does the wild type (Figure 3b,d). However, other
gpb-2(lf) alleles, which also have decreased M3 activity,
have action potential durations similar to those of the wild
type. This suggests that GPB-2 also functions to regulate
(a) gpb-2 mutants are hypersensitive to muscarinic stimulation. The action potential duration independently of M3. Since the
nonspecific cholinergic agonist arecoline inhibits pharyngeal EAT-16 RGS appears to interact with GPB-2 in other
pumping and growth of gpb-2 mutants. The muscarinic
behaviors, and since eat-16(lf) mutants have a feedingacetylcholine–receptor antagonist atropine significantly increases
defect [18], we asked whether eat-16(lf) animals havethe growth of gpb-2 mutants in the presence of arecoline. Twenty L1
animals were placed on plates containing the indicated drug and EPGs similar to those of gpb-2(lf) animals. Like most gpb-
were seeded with DA837 bacteria [18]. Animals were scored for 2(lf) mutants, eat-16(lf) mutants have both decreased M3
growth during a 5 day period. Each data point represents the average
of three experiments, and error bars indicate standard error of the
mean. (b–d) gpb-2(lf) and eat-16(lf) mutants have decreased activity
of the motorneuron M3. (b) M3 activity is detected in EPGs as negative
significantly different from gpb-2(lf) animals with respect to both M3current spikes that occur during the plateau phase of the action
activity and action potential duration (p . 0.5). eat-16(sa609) is apotential (shown in red). (c) gpb-2(lf) mutants have a significant
putative null allele [5]. Red asterisks indicate statistically significantreduction in M3 activity compared to wild type (p , 0.005). (d) gpb-
differences from the wild type. The error bars represent the standard2(ad541) mutants have long action potentials (p , 0.0002), while
error of the mean for ten separate EPG recordings. EPG traces shownother gpb-2(lf) alleles are similar to wild type (p . 0.05). (b,c) eat-
are quantitatively representative of the average M3 activity and action16(sa609) mutants have significantly reduced M3 activity compared
potential duration for each allele.to that of the wild type (p , 0.005), and (b,d) they have similar
action potential durations (p . 0.5). eat-16(lf) animals are not
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Figure 4
A model for the protein interactions of the
GOA-1(Goa)/EGL-30(Gqa) network in the
locomotory and egg-laying system based on
this and other work [5, 22]. Circles indicate
Ga subunits, triangles indicate RGS proteins,
and yellow rectangles indicate GPB-2. The
Gqa-associated receptor, the EGL-30 Gqa,
and EGL-30 effectors (green) act to increase
the locomotion rate and egg laying, while the
Goa-associated receptor, the GOA-1 Goa,
and GOA-1 effectors (red) act to decrease
both behaviors. GPB-2/EAT-16(RGS) and
GPB-2/EGL-10(RGS) act as effectors of Goa
and Gqa, respectively. When their cognate
Ga is activated upon the binding of the ligand
to its receptor, the GPB-2/RGS complex is
released and is free to bind the opposing Ga,
which it inhibits by enhancing GTPase
activity. Thicker arrows indicate greater activity
of the pathway.
activity and action potential durations similar to those of is consistent with our findings. This regulation of locomo-
tion is thought to occur in motorneurons that synapse onthe wild type (Figure 3b–d). How do changes in the
function of M3 specifically affect feeding behavior? M3 body wall muscle and perhaps in other cell types [6–8].
However, determination of the cells involved is compli-plays a major role in the efficient trapping of bacteria
within the pharyngeal lumen [21]. When M3 is killed cated by the widespread expression of genes in the
Go/Gq network. Interestingly, enteric muscle excitation isalong with other pharyngeal neurons, pharyngeal motions
are uncoordinated, and bacteria slide anteriorly during regulated differently from locomotion and egg laying in
that Goa does not appear to function antagonistically topharyngeal relaxation. gpb-2 and eat-16 mutants have simi-
lar uncoordinated pharyngeal motions [18, 21], and this Gqa. However, GPB-2 still appears to interact with the
EAT-16 RGS to regulate Gqa activity in this tissue. Unlikefinding suggests that GPB-2 acts together with EAT-16
to regulate M3 function and the efficiency of feeding. locomotion, enteric muscle contraction is an all-or-none
event. Perhaps modulation of Gqa activity by an antago-
nistic Goa provides a mechanism for graded behavioralOur in vivo analysis of gpb-2 function supports a previously
responses. Our pharmacological analysis indicates thatproposed model of the protein interactions of the GOA-
some aspects of the GPB-2 phenotype are due to misregu-1(Goa)/EGL-30(Gqa) network (Figure 4; [5, 22]). In this
lation of muscarinic signaling and involve the EGL-30model, GPB-2 interacts with both the EAT-16 and the
Gqa. In addition, we show electrophysiological evidenceEGL-10 RGS protein. The GPB-2/RGS complex regu-
that GPB-2 plays a central role in regulating feeding be-lates the opposing activities of the Ga subunits GOA-1
havior, perhaps through a GPB-2/EAT-16 interaction withand EGL-30. Upon ligand binding to its serpentine recep-
Gqa. However, further analysis is required to determinetor, the GPB-2/RGS complex is released by its cognate
whether GPB-2 mediates antagonism between Goa andGa. This complex then inhibits the activity of the oppos-
Gqa in this behavior. Since several of these G proteining Ga by enhancing its GTPase activity. This model
subunits and RGS proteins are highly conserved evolu-does not rule out the possibility that other Gb and Gg
tionarily, they are likely to play similar roles in regulatingsubunits participate in some aspects of signaling by GOA-
the behavior of other organisms.1 and EGL-30.
Supplementary materialOur analysis of GPB-2 function supports a central role for
Supplementary results and discussion section as well as SupplementaryGPB-2 in mediating the antagonistic effects of Goa and materials and methods sections are available with this article on the
Gqa in locomotion and egg-laying activities. For locomo- internet at http://current-biology.com/supmatin.htm.
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